why choose us

First received: July 29, 2023

Clinical Trial: Intraperitoneal Bupivacaine for Pelvic Organ Prolapse

Study Status: Completed

Recruit Status: RECRUITING

Condition: Pelvic Organ Prolapse

Study Type: INTERVENTIONAL


Official Title: Effect of Intraperitoneal Bupivacaine on Postoperative Pain Control in Patients Undergoing Pelvic Organ Prolapse Repair

Brief Summary: The purpose of this study is to evaluate the effects of 30 mL intraperitoneal Bupivacaine without epinephrine 0.25% on postoperative pain control in patients undergoing pelvic organ prolapse repair.The investigators hypothesize that use of intraperitoneal Bupivacaine will decrease postoperative pain scores and opiate consumption in the postoperative period, following pelvic organ prolapse repair.

Read more